Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin

Reproductive Sciences

Volumn 15, Issue 6, 2008, Pages 552-558

  Kim, Dong Chul ^a   Ramachandran, Sabarish ^b   Baek, Seung Hee ^a   Kwon, Sang Hoon ^b   Kwon, Kun Young ^b   Cha, Soon Do ^b   Bae, Insoo ^c   Cho, Chi Heum ^b  

^a Daegu Haany University   (South Korea)

^b Keimyung University   (South Korea)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Human uterine leiomyoma; Isoliquiritigenin

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; ISOLIQUIRITIGENIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR E2F;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; UTERUS MYOMA; WESTERN BLOTTING;

ADULT; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHALCONES; FEMALE; HUMANS; LEIOMYOMA; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 45749142839     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107312681     Document Type: Article

References (28)

1. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med. 1993 ; 328: 856-860.
2. ButtramVC Jr, Reiter RC Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981 ; 36: 433-445.
3. Cui,YJ Liu P., Chen RY Studies on the chemical constituents of Spatholobus subrectus Dunn. Yao Xue Xue Bao. 2002 ; 37: 784-787.
4. Haraguchi H., Ishikawa H., Mizutani K., Tamura Y., Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem. 1998 ; 6: 339-347.
5. Tawata M., Aida K., Noguchi T., Ozaki Y., Kume S., Sasaki H. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol. 1992 ; 212: 87-92.
6. Aida K., Tawata M., Shindo H., et al. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix. Planta Med. 1990 ; 5: 254-258.
7. Tamir S., Eizenberg M., Somjen D., Izrael S., Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol. 2001 ; 78: 291-298.
8. Yamamoto S., Aizu E., Jiang H., et al. The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis. 1991 ; 12: 317-323.
9. Baba M., Asano R., Takigami I., et al. Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull. 2002 ; 25: 247-250.
10. Kobayashi S., Miyamoto T., Kimura I., Kimura M. Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro. Biol Pharm Bull. 1995 ; 18: 1382-1386.
11. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem. 2000 ; 64: 1813-1820.
12. Ma J., Fu NY, Pang DB, Wu WY, Xu AL Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med. 2001 ; 67: 754-757.
13. Otubu JA, Buttram VC, Besch NF, Besch PK Unconjugated steroids in leiomyomas and tumor-bearing myometrium. Am J Obstet Gynecol. 1982 ; 143: 130-133.
14. Kawaguchi K., Fuji S., Konishi I., Nanbu Y., Nonogaki H., Mori T. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol. 1989 ; 160: 637-641.
15. Stewart EA, Friedman AJ Steroidal treatment of leiomyomas: preoperative and long-term medical therapy. Semin Reprod Endocrinol. 1992 ; 10: 344-357.
16. Rein MS, Barbieri RL, Friedman AJ Progesterone: a critical role in the pathogenesis of uterine leiomyomas. Am J Obstet Gynecol. 1995 ; 172: 14-18.
17. Brandon DD, Erickson TE, Keenan EJ, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 1995 ; 80: 1876-1881.
18. Viville B., Charnock-Jones DS, Sharkey AM, Wetzka B., Smith SK Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod. 1997 ; 12: 815-822.
19. Walker CL, Burroughs KD, Davis B., Sowell K., Everitt JI, Fuchs-Young R. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma. J Soc Gynecol Investig. 2000 ; 7: 249-256.
20. Burroughs KD, Fuchs-Young R., Davis B., Walker CL Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod. 2000 ; 63: 1322-1330.
21. Chiaffarino F., Parazzini F., La Vecchia C., Chatenoud L., Di Cintio E., Marsico S. Diet and uterine myomas. Obstet Gynecol. 1999 ; 94: 395-398.
22. Morris ME, Zhang S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci. 2006 ; 78: 2116-2130.
23. Harper JW, Adami GR, Wei N., Keyomarsi K., Elledge SJ The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993 ; 75: 805-816.
24. XiongY., Hannon GJ, Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993 ; 366: 701-704.
25. Kokunai T., Izawa I., Tamaki N. Overexpression of p21WAF1/ CIP1 induces cell differentiation and growth inhibition in a human glioma cell line. Int J Cancer. 1998 ; 75: 643-648.
26. Datto MB, Yu Y., Wang XF Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem. 1995 ; 270: 28623-28628.
27. Biggs JR, Kudlow JE, Kraft AS The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. JBiol Chem. 1996 ; 271: 901-906.
28. Nakano K., Mizuno T., Sowa Y., et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem. 1997 ; 272: 22199-22206.